Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disseminated HER2+ Breast Cancer”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Not applicableStudy completedNCT01645059
What this trial is testing

Multicenter Descriptive Study of the Patient Clinical Profile That Begins With Disseminated Her 2 + Breast Cancer or Develops a Metastasis After or During the Adjuvant Therapy

Who this might be right for
Disseminated HER2+ Breast Cancer
Asociación Cacereña para la Investigación y el Desarrollo en Oncología Médica 129
Testing effectiveness (Phase 2)WithdrawnNCT01757327
What this trial is testing

LDE225 in Treating Patients With Stage II-III Estrogen Receptor- and HER2-Negative Breast Cancer

Who this might be right for
Breast Neoplasms
Washington University School of Medicine
Testing effectiveness (Phase 2)Study completedNCT01367288
What this trial is testing

Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast Cancers

Who this might be right for
Locally Advanced Breast CancerDuctal Histologic TypeWithout Her 2 Overexpression
Hospices Civils de Lyon 53
Not applicableStudy completedNCT01433926
What this trial is testing

Characteristics of Disseminated Her2+ Breast Cancer Patients Treated With Trastuzumab That Have Reached Complete, Partial Remission or Stabilization of Disease During More Than 3 Years

Who this might be right for
HER-2 Positive Breast Cancer
Asociación para el Progreso de la Oncología en Málaga 114
Testing effectiveness (Phase 2)Ended earlyNCT01779050
What this trial is testing

Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells

Who this might be right for
Breast Neoplasms
Washington University School of Medicine 7
Testing effectiveness (Phase 2)Looking for participantsNCT04333706
What this trial is testing

A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)

Who this might be right for
BreastMetastaticTriple Negative+2 more
University of Southern California 65
Not applicableStudy completedNCT03961880
What this trial is testing

Impact of Recurrence Score on Adjuvant Treatment Decisions in Breast Cancer Patients

Who this might be right for
Breast Cancer Female
University Hospital Tuebingen 270